10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10
** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.

Hybrid Event

30th - 31st July 2026 | Sylhet, Bangladesh

International Conference on Microbial Drug Discovery and Therapeutics (ICMDDT - 26)

4

Days

4

Hrs

07

Min

02

Sec

Conference Program

Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

Why it matters

SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
Explore All Session Tracks
Track 01
Innovations in Antimicrobial Drug Discovery

This track focuses on the latest advancements in the discovery of antimicrobial agents. It will explore novel compounds, mechanisms of action, and the potential for overcoming resistance.

Track 02
Molecular Diagnostics in Microbial Pathogenesis

This session will delve into cutting-edge molecular diagnostic techniques for identifying microbial pathogens. Emphasis will be placed on their application in clinical settings and their role in improving patient outcomes.

Track 03
Translational Research in Microbial Therapeutics

This track aims to bridge the gap between laboratory research and clinical application of microbial therapeutics. Discussions will include successful case studies and challenges faced in translational research.

Track 04
Clinical Research on Antimicrobial Resistance

This session will address the growing challenge of antimicrobial resistance in clinical settings. Researchers will present findings on resistance mechanisms and strategies for effective management.

Track 05
Laboratory Techniques in Microbial Drug Development

This track will highlight innovative laboratory techniques used in the development of microbial drugs. Participants will discuss methodologies that enhance the efficiency and effectiveness of drug discovery.

Track 06
Pathogen-Host Interactions: Implications for Therapy

This session will explore the complex interactions between pathogens and their hosts. Understanding these dynamics is crucial for developing targeted therapeutic strategies.

Track 07
Therapeutic Innovations in Microbial Infections

This track will showcase novel therapeutic approaches for treating microbial infections. Emphasis will be placed on innovative strategies that address current limitations in treatment.

Track 08
Biotechnology Applications in Microbial Drug Discovery

This session will focus on the role of biotechnology in enhancing microbial drug discovery processes. Participants will discuss biotechnological advancements that facilitate the identification and development of new therapeutics.

Track 09
Emerging Trends in Microbial Therapeutics

This track will examine emerging trends and future directions in microbial therapeutics. Discussions will include the impact of new technologies and research findings on therapeutic development.

Track 10
Regulatory Challenges in Microbial Drug Development

This session will address the regulatory landscape surrounding microbial drug development. Experts will discuss the challenges and opportunities in navigating regulatory pathways for new therapeutics.

Track 11
Global Perspectives on Microbial Drug Resistance

This track will provide a global overview of microbial drug resistance and its implications for public health. Participants will share insights on international efforts to combat resistance and promote effective therapies.

2026 UPDATE

Consistent Academic Support

Science Net ensures that research activities continue without interruption in the current global situation. Participants can engage through digital and hybrid conference formats.